Plain-English translation of NCT05501483 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how three different diabetes medications—empagliflozin, pioglitazone, and semaglutide—affect your body's fat tissue and blood sugar levels. Each medication works in a slightly different way, and this study will help doctors learn which approach might work best for different people. By comparing these three treatments side by side, the research team hopes to personalize diabetes care.
Type 2 diabetes affects how your body handles blood sugar, and the way medications work can differ from person to person. Researchers believe that understanding how these treatments affect fat tissue—not just blood sugar numbers—could help doctors choose the right medication for each patient's unique situation.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take one of the three medications over the course of the study. Researchers will monitor your blood sugar levels, measure changes in your fat tissue and body weight, and track how well the medication works for you. The study involves regular clinic visits where blood tests and other measurements will be taken to see how your body responds to the treatment.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Sweden